1. Conservative Recommendation
Gilead Sciences Inc. (GILD)
Gilead is a current recommendation in my weekly trading service, Alpha Algorithm.
Two pieces of news have driven Gilead’s stock up 9% this past week. Each is worth highlighting.
First, Gilead announced it.s $11.9 billion acquisition of Kite Pharmaceuticals (KITE)
Second, Swiss drug maker Novartis’ (NVS) Kymriah, a game-changing CAR-T cancer drug, won Federal Drug Administration (FDA) approval this week. That increases the odds that the FDA also will approve Kite Pharma’s CAR-T Axi-Cel in November.
Gilead is currently a 100% “buy,” based on all of my short-, medium- and long-term technical indicators.
2. Aggressive Recommendation
CBOE Holdings, Inc. (CBOE)
CBOE Holdings, Inc. — a holding in Momentum Trader Alert — is making its second appearance in the past month in this weekly update.
CBOE’s relative strength in even weak markets remains impressive. The stock rose 1.25% yesterday even in the midst of a sharp market sell-off.
CBOE Holdings’ shares have surged 38.31% year to date, outperforming the S&P 500, which gained 10.08% over the same period.
Technically, the stock is in a strong uptrend and scores 100% on all of the Momentum Trader Alert technical indicators.